The European Approach to Nanoregulation

Nanoscale: Issues and Perspectives for the Nano Century

Volumn , Issue , 2007, Pages 189-210

  Phelps, Trudy A ^a  

^a Association of British Healthcare Industries (ABHI)   (United States)

Author keywords

European approach to nanoregulation; Harmonized testing procedures and risk assessment methodologies; Nanotechnology and use of standardization

Indexed keywords

EID: 72449187243     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470165874.ch12     Document Type: Chapter

References (49)

1. Treaty establishing the European Community (Official Journal C325 of 24 Dec. 2002), Part Three-Community policies, Title XIII, Public Health, Article 152.
2. Treaty establishing the European Community (Official Journal C325 of 24 Dec. 2002), Part Three-Community policies, Title XIII, Consumer Protection, Article 153.
3. Available at http://www.euractiv.com/en/agenda2004/lisbon-agenda/article-117510.
4. Nanotechnologies: A preliminary risk analysis on the basis of a workshop organized in Brussels on 1-2 March 2004 by the Health and Consumer Protection Directorate General of the European Commission, Available at http://ec.europa.eu/health/ph_risk/events_risk_en.htm.
5. Nanosciences and nanotechnologies: An action plan for Europe 2005-2009, COM(2005) 243 final, Communication from the Commission to the Council, the European Parliament and the Economic and Social Committee.
6. Guide to the implementation of directives based on the New Approach and the Global Approach, European Communities, 2000. Available at: http://europa.eu.int/comm./enterprise/newapproach/ newapproach.htm.
7. Available at http://ec.europa.eu/enterprise/newapproach/standardization/harmstds/index_en.html.
8. The Innovation Society is a Swiss research and consulting company focussing on business applications and economic impacts of nanotechnology. Available at www.innovationsociety.ch.
9. Nano-Regulation-A multistakeholder-dialogue-approach toward a sustainable regulatory framework for nanotechnologies and nanosciences (March 2006), Christoph Meili, The Innovation Society, Ltd, St. Gallen, Switzerland.
10. -9 m (1-billionth of a meter).
11. The international equivalent standardization organizations are ISO (International Standards Organization), IEC (International Electrotechnical Commision), and ITU (International Telecommunications Union).
12. PAS 71: 2005 Vocabulary-Nanoparticles (ISBN 0-580-45925-X). Available at www.bsi-global.com/ nano.
13. CEN/STAR Recommendations for ERA (the European Research Area) and the 7th FWP (7th Framework Programme), Ref: SG CORR/11125, in letter to Mr. J. Potocnik, Commissioner for Research, European Commission dated December 6, 2004. Available at http://cordis.europa.eu/documents/ documentlibrary/2483EN.pdf (accessed August 6, 2006).
14. Nanoscience and nanotechnologies: opportunities and uncertainties. London: The Royal Society and The Royal Academy of Engineering, 2004. Available free of charge at www.royalsoc.ac.uk/policy and on www.raeng.org.uk.
15. Nanotubes are a specific tube-like form of carbon nanoparticles.
16. Government response to the Royal Society and Royal Academy of Engineering Report "Nanoscience and nanotechnologies: opportunities and uncertainties." London: DTI, HM Government (2005).
17. Council Directive 67/548/EEC of 27 June 1967 on the approximation of laws, regulations, and administrative provisions relating to the classification, packaging and labeling of dangerous substances.
18. EINECS (European Inventory of Existing Commercial chemical Substances) database is a database of chemicals on the European Community market between January 1, 1971, and September 18, 1981. It is maintained by the European Chemicals Bureau. Any chemical marketed after September 18, 1981, is a "new" chemical.
19. Dangerous Substances Directive (67/548/EEC).
20. Review of the adequacy of current regulatory regimes to secure effective regulation of nanoparticles created by nanotechnology, HSE. Available at www.hse.gov.uk/horizons/nanotech, published March 2006.
21. European Inventory of Existing Chemical Substances (EINECS).
22. The 12th International Workshop on Quantitative Structure-Activity Relationships in Environmental Toxicology, 2006 (Poster) (accessed August 11, 2006). Available at http://ecb.jrc.it/home.php? CONTENU+/DOCUMENTS/QSAR/INFORMATION_SOURCES/PRESENTATIONS/Bassan_Lyon_ 0605_poster.pdf.
23. Council Directive 67/548/EEC of 27 June 1967 on the approximation of laws, regulations and administrative provisions relating to the classification, packaging and labeling of dangerous substances.
24. Regulation (EC) No. 1907/2006.
25. Powders composed of particles on the nanoscale range of approximately 1-100 nm. Other terms for nanopowders are "nanoparticles," "nanomaterials," and "ultrafine particles."
26. Directive 1999/92/EC of the European Parliament and of the Council of December 16, 1999 on minimum requirements for improving the safety and health protection of workers potentially at risk from explosive atmospheres.
27. Directive 94/9/EC of the European Parliament and the Council of March 23, 1994 on the approximation of the laws of the Member States concerning equipment and protective systems intended for use in potentially explosive atmospheres.
28. Literature review-explosion hazards associatedwith nanopowders (HSL/2004/12).Author(s):DKPritchard, BSc, PhD, CChem, MRSC. Available at http://www.hse.gov.uk/research/hsl_pdf/2004/hsl04-12. pdf#search = 'HSE%20explosion%20hazards%20associated%20with%20nanopowders%20%28HSL%2F2 004%2F12%29' (accessed October 18, 2006).
29. The nanosize range is usually thought of as being between 1 and 100 nm.
30. "Remediation" is the cleanup of an environmentally contaminated site. Nanofilters are able to remove biological toxins and toxic metals from water, and nanoremediation is a promising application of nanotechnology to environmental problems.
31. Directive 2000/53/EC.
32. Defra consultation on a Voluntary Reporting Scheme for engineered nanoscale materials-Summary of findings and government's response, August 2006. Available at http://www.defra.gov.uk/corporate/ consult/nanotech-vrs/nanotechvrs-consultfindings.pdf.
33. Each UK regulatory authority has an independent scientific advisory body to give advice relevant to the topic concerned (e.g., there are advisory committees for carcinogenicity, mutagenicity, and toxicity of chemicals in food, consumer products, and the environment).
34. Draft report of FSA regulatory review of the use of nanotechnologies in relation to food, March 2006. Available at http://www.foodstandards.gov.uk/Consultations/ukwideconsults/2006/nanotech.
35. FDF response to FSA draft report of regulatory review of the use of nanotechnologies in relation to food. Available at http://www.fdf.org.uk/responses/fdf_response_nano.pdf.
36. Regulation (EC) 1935/2004 of the European Parliament and of the Council of 27 October 2004 on materials and articles intended to come into contact with food.
37. Council Directive 76/768/EEC of 27 July 1976 on the approximation of the laws of the Member States relating to cosmetic products.
38. Scientific Committee on Cosmetic Products and Non-Food Products.
39. Opinion concerning Titanium Dioxide, Colipa n S75 adopted by the SCCNFP during the 14th plenary meeting of October 24, 2000. Available at http://ec.europa.eu/health/ph_risk/committees/sccp/ docshtml/sccp_out135_en.htm.
40. Medicinal Products Directive 2001/83/EC, Council Directive of 6 November, 2001. Available from: http://ec.europa.eu/enterprise/pharmaccuticals/eudralex/vol-1/consol_2004/human_code.pdf.
41. Council Directive 93/42/EEC of June 14, 1993 concerning medical devices.
42. Council Directive 90/385/EEC of June 20, 1990 on the approximation of the laws of the Member States relating to active implantable medical devices.
43. Council Directive 98/79/EC of October 27, 1998 on in vitro diagnostic medical devices.
44. Tissue engineering is the regeneration of biological tissue through the use of cells, with the aid of supporting structures (that may be mechanical scaffolds) and/or biomolecules. The cells used may be human or animal derived.
45. Reflection paper on nanotechnology-based medicinal products for human use, EMEA/CHMP/79769/ 2006, June 29, 2006.
46. Announcement of formation of new task force available at: http://www.emea.eu.int/htms/human/itf/itfintro.htm.
47. Science and innovation investment framework 2004-2014, Part 7 "Science and Society." Available at http://www.hm-treasury.gov.uk/spending_review/spend_sr04/associated_documents/spending_sr04_ science.cfm.
48. 4th Nanoforum Report: Benefits, Risks, Ethical, Legal and Social Aspects of Nanotechnology. Part 7: the need for and rise of new legislation and regulation caused by the emergency of Nanotechnology, 2nd Edition-October 2005.
49. Nanotechnologies: A preliminary risk analysis on the basis of a workshop organized in Brussels on 1-2 March 2004 by the Health and Consumer Protection Directorate General of the European Commission.